Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 816 of 6351
-
New Clot-Busting device could save lives in pulmonary embolism
Disease control OngoingEvaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.
Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Weight-Loss drug tirzepatide aims to help people keep pounds off Long-Term
Disease control CompletedThe main purpose of this study is to evaluate the efficacy and safety of tirzepatide for the maintenance of body weight reduction.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Radioactive bullet targets Hard-to-Treat prostate cancer
Disease control OngoingResearchers are looking for a better way to treat people who have advanced metastatic castration-resistant prostate cancer (mCRPC). In participants with metastatic castration-resistant prostate cancer (mCRPC), the cancer of the prostate has spread to other parts of the body (meta…
Phase 1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
A phone call could ease chronic pain and depression in older veterans
Symptom relief CompletedThe proposed study seeks to evaluate effectiveness, implementation processes, and cost of MOTIVATE among older Veterans with chronic musculoskeletal (MSK) pain and comorbid depressive symptoms.
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a Two-Pronged attack shrink Hard-to-Treat cancers?
Disease control Stopped earlyIn this study, participants with different types of advanced solid tumors who failed standard treatments will be treated with XNW5004 in combination with KEYTRUDA® (pembrolizumab) .
Phase 1/2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New vaccine aims to tackle two viruses behind hand, foot, and mouth disease
Vaccine CompletedThe Phase I clinical trial is divided into two parts. The first part uses an open-label design, while the second part uses a randomized, double-blind, and controlled design. The goal of this clinical trial is to evaluate the tolerability and safety of a bivalent (EV71/CA16, Enter…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 28, 2026 00:00 UTC
-
Can newer cataract lenses keep vision clear for years?
Disease control CompletedThe purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Sponsor: Alcon Research • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
HIV vaccine candidate VIR-1388 passes early safety check in 93 volunteers
Vaccine CompletedThe purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity of VIR 1388 in adults in good health without HIV.
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 09:09 UTC
-
Spine surgery samples could reveal silent heart disease
Diagnosis Recruiting nowPrimary objective: To identify older adults with transthyretin cardiac amyloidosis (ATTR-CA) early in the course of the illness, at a time when disease modifying therapies are most effective. The specific aims of this epidemiologic investigation include: 1. To identify subject…
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New hope for breast cancer brain metastases? drug combo trial launches
Disease control Recruiting nowThis study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in breast cancer Patients with brain metastases.
Phase 2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising drug cocktail targets Hard-to-Treat liver cancer
Disease control CompletedTo evaluate the efficacy and safety of cadonilimab combined with regorafenib in patients with HCC who progressed on systemic therapy.
Phase 1/2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can school staff stop child trafficking? kentucky trial aims to find out
Prevention Recruiting nowFocus: Intervention \& prevention of child commercial sexual exploitation or trafficking (CST) In Kentucky, familial SU/D increases risk of CST. Primary goal: Implement and evaluate effectiveness of multi-level bystander-informed program (CSTOP Now!) aimed at Kentucky public mid…
Sponsor: Ann Coker • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Can a radioactive peptide spot hidden amyloid in the heart?
Diagnosis Recruiting nowThis study will investigate 99mTc-p5+14, an amyloid-reactive synthetic peptide, p5+14, radiolabeled with technetium-99m, as a radiotracer for detecting paamyloid deposits in patients with AL or ATTR-associated systemic amyloidosis, notably with cardiac involvement.
Phase 1 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Metronome beat may retrain walking after stroke
Symptom relief CompletedStroke is among the leading causes of long-term disability worldwide. Post-stroke neuromotor impairments are heterogeneous, yet often result in reduced walking ability characterized by slow, asymmetric, and unstable gait patterns. Rhythmic Auditory Stimulation (RAS) is an emergin…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a pill target a common cancer mutation?
Disease control CompletedThis is a two-phase, multicenter, open phase I clinical study, with phase Ia as dose escalation phase and phase Ib as dose expansion phase, to evaluate the safety tolerability and pharmacokinetic characteristics of BEBT-607 tablets in patients with advanced or metastatic solid tu…
Phase 1 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Gut bacteria pill may shield HIV patients from heart disease
Disease control Recruiting nowAmong people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will deter…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new CT scan spot tiny gut lesions that older scans miss?
Diagnosis CompletedThis comparative matched-cohort study aims to evaluate the diagnostic performance of contrast-enhanced photon-counting computed tomography (PCCT) for detecting small gastrointestinal lesions compared with energy-integrating detector dual-energy computed tomography (DECT). The stu…
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Could a pill replace the CPAP machine for sleep apnea?
Symptom relief CompletedThis is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obstructive Sleep Apnea.
Phase 3 • Sponsor: Apnimed • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
A simple walk after surgery might cut recovery time
Disease control CompletedObjectives: This study will be conducted to determine the effect of early mobilization on postoperative recovery in abdominal surgery patients.. Methods: This research is a randomized controlled experimental study. In the Gastrointestinal Surgery Department, a total of 130 patie…
Sponsor: Cumhuriyet University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Cutting radiation in CT scans: a new test of Ultra-Low-Dose imaging
Diagnosis CompletedThe new image reconstruction algorithm (Precise Image, Philips Healthcare) has a strong potential to maintain sufficient image quality suitable for diagnosis with ultra-low dose (ULD) chest and abdomen-pelvis scans. The hypothesis is that the images obtained with the Precise Ima…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC